This webpage contains content about the scientific work of the independent Researcher Christoph Gassner Priv. Doz. Dr. rer. nat., his CV, publications, interests as well as some private information.
occupation (16) pub (57) private (7) external link (3)
Austrian. Biologist. Thesis on phage T1-DNA-methyltransferase in Innsbruck. HLA and non HLA immunogenetics, blood group variants and genotyping from 1994 to 2010 at Blood Transfusion Service (BTS) in Innsbruck. PostDoc on KIR genetics at FHCRC in Seattle (1999) and Basel Institute for Immunology (2000). Head of Molecular Diagnostics and R&D Blood Transfusion Service, Swiss Red Cross, Zurich, Switzerland, 2010 to 2019. Associate Editor “Transfusion Medicine and Hemotherapy” starting 2005, Chair (joint) of the ISBT working party “Blood Group Terminology” starting 2018.
List of selected journals including papers that C. Gassner have authored (up to 2019).
Blood Rev (1)
Br J Haematol (3)
Eur J Immunogenet (1)
Eur J Immunol (1)
Forensic Sci Int Genet (2)
GeneReviews® [Internet]. Seattle (WA): University of Washington (1)
Immun Ageing (1)
Immunol Lett (1)
Int J Legal Med (1)
Int J Rheum Dis (1)
J Clin Oncol (1)
J Immunol (1)
J Mol Diagn (1)
J Neuroimmunol (1)
J Pediatr Hematol Oncol (1)
Methods Mol Biol (1)
Parkinsonism Relat Disord (1)
PLoS One (1)
PLoS Pathog (1)
Rev Immunogenet (1)
Seattle; 1993-2019. (1)
Tissue Antigens (5)
Transfus Apher Sci (3)
Transfus Med (1)
Transfus Med Hemother (8)
Transfus Med Hemother. (1)
Transfus Med Rev (1)
Transplant Proc (1)
Vox Sang (4)
Brief Curriculum Vitae
Christoph Gassner Priv. Doz., PhD.
Zurich, Switzerland firstname.lastname@example.org
Independent Researcher Immunogenetics & Immunohematology
Together with Catherine A. Hyland of the Australian Red Cross, Brisbane, Australia, election as Co-Chair of the Working Party “Red Cell Immunogenetics and Blood Group Terminology”, a 4 year term. http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-group-terminology/
Implementation and Swiss SAS accreditation (STS 0447) of digital PCR for routine diagnosis of chimerism, post bone marrow transplantation.
Submission of patent application on molecular diagnosis of MNSs blood group system S-s-U- phenotype causing GYPB deletions (Nr. PCT/EP 2017/080230).
End of project: “High-throughput blood group genotyping using MALDI-TOF MS”, 37’000 blood donors from 11 Swiss blood transfusion services genotyped for a total of 1.3 Mio. blood group SNPs, 333 donors with rare blood groups identified, routine blood group genotyping for major antigens implemented and accredited with the Swiss SAS (STS 0447). Funded by the Humanitarian Foundation of the Swiss Red Cross. Overview published in <Transfus Med Rev. 2013 Jan;27(1):2-9. doi: 10.1016/j.tmrv.2012.10.001.>
Listing of Blutspende Zurich at NCBI Genetic Testing Registry (Orphanet starting from October 2013) as specialized laboratory for genetic testing of XK mutations causing McLeod syndrome.
April 2010 - April 2019
Blood Transfusion Service Zurich, Swiss Red Cross, Zurich, Switzerland. Head of Molecular Diagnostics and Research & Development.
Assignment as “Expert trainer for Immunogenetics” by the Deutsche Gesellschaft für Immungenetik (DGI), and the examination board of the DGI.
Fulfillment of qualification for the function of a “Director/Codirector” according to the guidelines of the European Federation of Immunogenetics (EFI). Assignment as associate editor of the Journal <Transfusion Medicine and Hemotherapy>.
“Habilitation” in medical biology, topic: “Genotyping of human blood groups, with special attention to the blood group Rhesus.” Appointment as manager of “Research and Development (R&D)”.
Head of “Molecular Blood Group Diagnostics”. Attendance at an accredited Master of Business Administration program one year course on: “Management of Innovations, Products and Processes”, held by the Management Center Innsbruck (MCI), Austria.
March 2001 - March 2010
Central Institute for Blood Transfusion & Immunology, Innsbruck, Austria. Deputy Head of the HLA / DNA-laboratory.
March 2000 - February 2001
Laboratory of Dr. Marco Colonna at the Basel Institute for Immunology, Switzerland. Postdoc, recipient of “Erwin-Schroedinger-Stipendium” (fellowship) of the Austrian Science Fund for project:“ Killer Cell Inhibitory (Ig-like) Receptor (KIR) and Immunoglobulin-like transcript 5 (ILT5) genes of human Chromosome 19: Genotyping and role in the susceptibility to genetic atopy and asthma“.
March 1999 - February 2000
Laboratory of Dr. Daniel E. Geraghty at the Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Postdoc, recipient of “Erwin-Schroedinger-Stipendium” (fellowship) of the Austrian Science Fund for project: “Defining the genomic organisation of the killer cell inhibitory receptor (kir) locus on human chromosome 19“.
December 1994 - February 1999
Central Institute for Blood Transfusion & Immunology, Innsbruck, Austria. Deputy Head of HLA / DNA-laboratory. Establishment of DNA-typing techniques (HLA class I, class II high resolution)
February 1994 - November 1994
Civil Servant at the Central Institute for Blood Transfusion and Immunological Department (CIBT) / General Hospital and University Clinics Innsbruck / Austria.
October 1990 - Jannuary 1994
Thesis at the Institute for Biochemistry / University of Innsbruck (B. Auer): ”T1 DNA-Methyltransferase: Functional Analysis, Expression and Purification of the Recombinant Protein” (graduated with excellence)
March 1989 - June 1990
Diploma at the Institute for Biochemistry / University of Innsbruck (M. Schweiger): ”Cloning of the SAM:DNA-Methyltransferase of Escherichia coli Virus T1”(graduated with excellence)
1984 - 1990
University of Innsbruck, Subject Biology, sub-subject, Microbiology, optional subject, Biochemistry
1976 - 1984
High school Bregenz / Austria
28. May 1966
Born in Lustenau / Austria